Postnatal Mental Health: Recognising the Signs and Taking Care
An article by clinical psychologist Ana Beatriz Sousa explaining the importance of mental health after giving birth.
Read more
Cryopreserving umbilical cord blood and tissue is, nowadays, an important option for parents with regard to their baby's future and even that of their own family.
The umbilical cord is an excellent reservoir of stem cells, and these cells have the ability to proliferate and differentiate into different types of cell populations in our body – they are called totipotent cells, which can divide indefinitely, self-renew and differentiate into cells with different functions and characteristics.
During embryonic development, stem cells specialise to give rise to the various types of cells in the body (heart muscle cells, neurons, red blood cells or skin cells). In adults, these cells are able to repair damaged tissue and replace cells as they die.
The cells are collected after the baby is born and the umbilical cord has been cut, a safe process with no risk to mother or baby. Cryopreservation should be carried out within the following 72 hours.
The cryopreservation process is simple. Biological cells or tissues are preserved for long periods at low temperatures, in liquid nitrogen at –196º C or in its vapour phase at -150º C, without losing cell viability even over long periods, namely 20 to 25 years. This technique allows stem cells isolated from umbilical cord blood and tissue, collected exclusively on the day of birth, to be cryopreserved for later clinical use if needed, whether for the child's own use or for a family member.
Stem cells are a therapeutic resource that has already been used to treat around 80 serious diseases, and this number is expected to grow in the future. The diseases in which these cells can be used as treatment include blood disorders (such as leukaemias, some types of anaemia or haemoglobinopathies), immune system disorders, metabolic diseases and also some cancers.
In Portugal, there are already recorded cases of successful allogeneic use (transplant with stem cells from a family donor) in the treatment of severe combined immunodeficiencies between siblings, with the patient making a full recovery. There are also cases of autologous use (transplant with the patient's own stem cells) in children with cerebral palsy. Around 80 umbilical cord blood transplants took place in Portugal between 2002 and 2019.
The list of success stories extends to many other countries. There are several cases of human tissues created from stem cells that have helped save lives.
So, given the current use of stem cells in everyday clinical practice, cryopreserving umbilical cord blood and tissue is strongly recommended – a choice that can make a difference to the life of a baby and their family.
By Dr Augusta Matos, Obstetrician and Gynaecologist,
Founder of Clínicas Augusta Matos
Comments (0)
Be the first to comment on this article.